GATTEX® (teduglutide [rDNA origin]) for Injection is a prescription medicine used in adults with Short Bowel Syndrome (SBS) who need additional nutrition or fluids from intravenous (IV) feeding (parenteral support).


Manage your GATTEX® communication preferences

If you no longer wish to receive communications from Gattex, enter your email address and check the box(es) below to indicate which communications you no longer wish to receive. You may choose to either unsubscribe from all communications or only certain types of communications. Click Submit when finished.

Email address is required A valid email is required

Unsubscribe from all GATTEX marketing communications

By clicking the box below, you are opting out of all marketing messages from GATTEX and OnePath®. Please note that if you are currently enrolled in OnePath, you will continue to receive personalized communications from your Patient Support Manager and Onboarding and Access Specialist, but will not receive communications about OnePath resources.

You have not checked any of the topics above.

Important Safety Information: GATTEX may cause serious side effects including making abnormal cells grow faster, polyps in the colon (large intestine), blockage of the bowel (intestines), swelling (inflammation) or blockage of your gallbladder or pancreas, and fluid overload.
Click here for additional Important Safety Information.